Investigation of the Effects of Video Based Training and Aerobic Exercise Training on Game Addiction Level and Functional Performance in Individuals With Internet Gaming Disorder
The Effects of Video Based Training and Aerobic Exercise Training in Individuals With Internet Gaming Disorder
Sponsors
Source
Hasan Kalyoncu University
Oversight Info
Has Dmc
No
Is Fda Regulated Drug
No
Is Fda Regulated Device
No
Brief Summary
In this study, video-based training, aerobic training and both training will be applied to
individuals with internet gaming disorder. Addiction levels and functional performance will
be evaluated before and after treatment.
Detailed Description
The aim of this study is to investigate the effect of game-based training and aerobic
exercise training on game addiction level, functional performance and exercise capacity in
individuals with internet play disorder. In addition, the investigators think that facilitate
the transition to exercise by using game-based training in order to gain exercise habit and
reduce sedentary behaviours in individuals with internet gaming disorder.
Overall Status
Recruiting
Start Date
2020-01-10
Completion Date
2020-11-05
Primary Completion Date
2020-10-05
Phase
N/A
Study Type
Interventional
Primary Outcome
Measure |
Time Frame |
|
Internet Gaming Disorder Scale-Short-Form (IGDS9-SF) |
2 Monthly change |
|
Senior Fitness Test (SFT) |
2 Monthly change |
|
cardiopulmonary exercise test |
2 Monthly change |
Secondary Outcome
Measure |
Time Frame |
|
Quality of Life Assessment: Short Form-36. |
2 Monthly change |
|
Anxiety Scale |
2 Monthly change |
Enrollment
45
Conditions
Intervention
Intervention Type
Other
Intervention Name
Description
Treadmill training is include warming, cooling and training phase according to rating of perceived exertion for participants.
Arm Group Label
aerobic exercise group
Other Name
Treadmill training
Intervention Type
Other
Intervention Name
Description
Exergame training include virtual reality games by xbox kinect.
Arm Group Label
Video based exercise group
Other Name
exergame
Intervention Type
Other
Intervention Name
Description
Combined group include virtual reality games and treadmill training
Arm Group Label
Combined group
Other Name
exergame and aerobic exercise
Eligibility
Criteria
Inclusion Criteria:
- DSM V (Diagnostic and Statistical Manual of Mental Disorders, revision 5) Internet
Gaming Impairment (IOOB) Diagnostic criteria: approval of five to nine items
- No communication barrier
- Playing game (smart phone,Play Station 4, Xbox, Personal Computer) at least 2 hours a
day in the last year
Exclusion Criteria:
- Cigarette use over 10 packsXyear
- be using any medicine
- Be actively involved in any sport.
- Having chronic disease
- Having physical disability
Gender
All
Minimum Age
18 Years
Maximum Age
N/A
Healthy Volunteers
Accepts Healthy Volunteers
Overall Contact
Last Name
Çağtay Maden, MSc, Pt
Phone
+0905439705709
cgty-mdn@hotmail.com
Location
Facility |
Status |
|
Hasan Kalyoncu Universty Gaziantep Şahinbey Turkey |
Recruiting |
Location Countries
Country
Turkey
Verification Date
2020-01-01
Lastchanged Date
N/A
Firstreceived Date
N/A
Responsible Party
Responsible Party Type
Sponsor-Investigator
Investigator Affiliation
Hasan Kalyoncu University
Investigator Full Name
Cagtay Maden
Investigator Title
research assistant,physiotherapist
Keywords
Has Expanded Access
No
Condition Browse
Number Of Arms
3
Arm Group
Arm Group Label
aerobic exercise group
Arm Group Type
Experimental
Description
Aerobic exercise group is received treadmill training.
Arm Group Label
Video based exercise group
Arm Group Type
Experimental
Description
Video based exercise group is received exergame training.
Arm Group Label
Combined group
Arm Group Type
Experimental
Description
Combined group is received both of exergame training and treadmill training.
Firstreceived Results Date
N/A
Overall Contact Backup
Last Name
Tuba Maden, MSc, Pt
Phone
+0905319340249
tuba.kaplan@hku.edu.tr
Firstreceived Results Disposition Date
N/A
Study Design Info
Allocation
Randomized
Intervention Model
Factorial Assignment
Intervention Model Description
participants are grouped randomly, the first group is the aerobic exercise group, the second group is the video based exercise group and the third group is the combination of these.
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)
Study First Submitted
January 8, 2020
Study First Submitted Qc
January 9, 2020
Study First Posted
January 13, 2020
Last Update Submitted
January 9, 2020
Last Update Submitted Qc
January 9, 2020
Last Update Posted
January 13, 2020
ClinicalTrials.gov processed this data on January 15, 2020
Conditions
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Interventions
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Study Phase
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.